Hematogenous candida vertebral osteomyelitis treated with ketoconazole

[1]  M. Pap,et al.  An Evaluation of two Years of Clinical Experience with Ketoconazole: Die Auswertung der klinischen Erfahrungen mit Ketoconazol über zwei Jahre , 1982, Mykosen.

[2]  H. B. Levine.  Ketoconazole in the management of fungal disease. , 1982 .

[3]  M. Borgers,et al.  The Activity of Ketoconazole on Clinical Isolates of Candida Albicans Cultured in a Mycelium Promoting Medium Die Wirkung von Ketoconazol auf Candida albicans aus klinischem Material unter Verwendung eines Mediums, das die Myzelbildung stimuliert. , 1981 .

[4]  J. Bennett,et al.  Miconazole in cryptococcosis and systemic candidiasis: a word of caution. , 1981, Annals of internal medicine.

[5]  M. De Brabander,et al.  The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. , 1981, Mykosen.

[6]  J. V. D. van der Meer,et al.  The influence of gastric acidity on the bio-availability of ketoconazole. , 1980, The Journal of antimicrobial chemotherapy.

[7]  H. B. Levine,et al.  Ketoconazole in early and late murine coccidioidomycosis. , 1980, Reviews of infectious diseases.

[8]  R. Courtney,et al.  Treating fungal infections. , 1980, British medical journal.

[9]  P. Appelbaum,et al.  Vertebral disc space infection and osteomyelitis due to candida albicans in a patient with acute myelomonocytic leukemia , 1980, Cancer.

[10]  J. Graybill,et al.  Suppression of cryptococcosis and histoplasmosis by ketoconazole in athymic nude mice. , 1980, The Journal of infectious diseases.

[11]  J. Heeres,et al.  Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. , 1979, Journal of medicinal chemistry.

[12]  A. Espinel-Ingroff,et al.  Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. , 1978, The Journal of infectious diseases.

[13]  Edwards Je,et al.  Severe Candidal Infections: Clinical Perspective, Immune Defense Mechanisms, and Current Concepts of Therapy , 1978 .

[14]  W. Merz,et al.  OPPORTUNISTIC MYCOTIC OSTEOMYELITIS: BONE INFECTIONS DUE TO ASPERGILLUS AND CANDIDA SPECIES , 1977, Medicine.

[15]  J. Hirschmann,et al.  Candida vertebral osteomyelitis. , 1976, The Journal of bone and joint surgery. American volume.

[16]  J. Edwards,et al.  Hematogenous candida osteomyelitis. Report of three cases and review of the literature. , 1975, The American journal of medicine.

[17]  A. Levine,et al.  Fungemia with compromised host resistance. A study of 70 cases. , 1974, Annals of internal medicine.

[18]  J. Zoll,et al.  Osteomyelitis of Cervical Spine: Candida guilliermondii , 1973 .

[19]  J. V. van Cutsem,et al.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. , 1972, Chemotherapy.

[20]  R. Holzman,et al.  Osteomyelitis in heroin addicts. , 1971, Annals of internal medicine.

[21]  J. Swayne.  Case of Puerperal Convulsions* , 1871, British medical journal.